Corporate Board Profile
Tech Score: 100/100
3 mention(s) identify STEPHEN B.H. KENT, PH.D. as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
ENZO BIOCHEM INC | 2008-11-28 | Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology (2001-present), Professor of Chemistry (2002-present). | Dr. Kent is a Professor of Biochemistry & Molecular Biology and has a strong academic background in science, indicating technical skills. |
ENZO BIOCHEM INC | 2011-11-28 | Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology and Professor of Chemistry at the University of Chicago. | Dr. Kent has a strong academic background in biochemistry and molecular biology, and has served as a director of biotech companies, indicating potential technical skills. |
ENZO BIOCHEM INC | 2012-11-27 | Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology at the University of Chicago. | Dr. Kent has a strong academic background in biochemistry and molecular biology, and has been involved in biotechnology companies, indicating familiarity with technical concepts, though not explicitly programming. |
Filing Date | Source Excerpt |
---|---|
2008-11-28 | Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology (2001-present), Professor of Chemistry (2002-present). |
2011-11-28 | Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology and Professor of Chemistry at the University of Chicago. |
2012-11-27 | Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology at the University of Chicago. |
Data sourced from SEC filings. Last updated: 2025-07-01